Exclusive interview

Fabricant: Gap between NDI numbers and submissions is too big 'no matter how you slice it'

It might be controversial, but the FDA's draft guidance on new dietary ingredients (NDIs) does not mean the end of the dietary supplements trade as we know it, insists Daniel Fabricant in an exclusive interview with NutraIngredients-USA at SupplySide West.

Talking with Stephen Daniells, Dr Fabricant fielded questions on the FDA's assessment on the time required for a notification, a definite grandfathered list, FDA's resources to cope with an anticipated avalanche of submissions, probiotics, and much more...

Fabricant: Gap between NDI numbers and submissions is too big 'no matter how you slice it'

It might be controversial, but the FDA's draft guidance on new dietary ingredients (NDIs) does not mean the end of the dietary supplements trade as we know it, insists Daniel Fabricant in an exclusive interview with NutraIngredients-USA at SupplySide West.

Related Topics

NDI guidance prompts unprecedented level of grassroots activism, claims ANH-USA

FDA grants comment period extension for NDI draft guidance

DSHEA co-author is ‘alarmed’ by NDI guidance